Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above
Clinical trial NCT04526990 · COMPLETED
Trial details
- NCT number
- NCT04526990
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2021-08-07
- Enrollment
- 44247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.